Cencora: High-Growth Specialty Services Firm Disguised As A Distributor [Seeking Alpha]
Cencora, Inc. (COR)
Last cencora, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.coresite.com/investor-overview
Company Research
Source: Seeking Alpha
Cencora's acquisition of OneOncology is a transformational event, prompting raised long-term EPS growth guidance to 10-14% and signaling structurally higher margins. Recent results show robust U.S. segment performance, with Q4 operating income up 25.1%, and fiscal 2026 guidance projecting 8-10% operating income growth. Key risks include leverage from the OneOncology deal, integration challenges, and regulatory headwinds, but strong cash flow and capital allocation underpin confidence. Tom Werner/DigitalVision via Getty Images Pharmaceutical distributors have traditionally been seen as a low-margin utility providing a service to support the volume-based needs of the healthcare industry. While Cencora ( COR ) has historically operated in this manner, it seems the This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I
Show less
Read more
Impact Snapshot
Event Time:
COR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COR alerts
High impacting Cencora, Inc. news events
Weekly update
A roundup of the hottest topics
COR
News
- Cencora (NYSE:COR) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
- Chief Executives for Corporate Purpose Announces Covista Chairman and CEO Steve Beard, Cencora Inc. Former Executive Chair Steven H. Collis, and Ann Fairchild, interim President and CEO of Siemens USA Joining Board of Directors [Yahoo! Finance]Yahoo! Finance
- Cencora (NYSE:COR) was upgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c+)" rating to a "buy (b)" rating.MarketBeat
- Cencora (COR) Stock Trades Up, Here Is Why [Yahoo! Finance]Yahoo! Finance
- Cencora (NYSE:COR) had its price target lowered by analysts at Evercore ISI from $440.00 to $420.00. They now have an "outperform" rating on the stock.MarketBeat
COR
Earnings
- 2/4/26 - Beat
COR
Sec Filings
- 2/10/26 - Form 424B5
- 2/10/26 - Form 8-K
- 2/4/26 - Form 10-Q
- COR's page on the SEC website